TY - JOUR T1 - TCH-033 Physicochemical Stability of Ready-To-Administer Epinephrine Injection Solutions 20 mg/ml, 50 ml JF - European Journal of Hospital Pharmacy: Science and Practice JO - Eur J Hosp Pharm SP - A80 LP - A80 DO - 10.1136/ejhpharm-2013-000276.224 VL - 20 IS - Suppl 1 AU - RM Heeb AU - I Kraemer Y1 - 2013/03/01 UR - http://ejhp.bmj.com/content/20/Suppl_1/A80.2.abstract N2 - Background In the University Medical Center Mainz standard concentrations are defined for medicinal products to be administered by continuous injection with syringe pumps in adult intensive care patients. Patient-individual doses are provided by adjusting the injection rate. Various medicines are aseptically prepared in the pharmacy department as ready–to-use products. Batch preparation of the products and keeping them in stock is only possible if stability of the products is tested using a validated method. Purpose The purpose of this study was to test the stability of ready-to-administer epinephrine solutions for injection 20 µg/ml in 50 ml plastic syringes. Materials and Methods Epinephrine bulk solution 20 µg/ml was prepared aseptically by diluting Suprarenin 25 mg/25 ml Sanofi-Aventis with 5% glucose infusion solution in empty infusion bags (PP/PE). The solution was filled with the NeoCare Compounder into 50 ml BD Perfusion Syringes, Luer Lock Tip, protected from light. The syringes were stored at 2–8°C in the refrigerator. Epinephrine concentration was determined by using a validated HPLC method with UV detection at 280 nm and an innovative HPLC column Nucleodur which contains sulfonyl groups. Results The concentration of epinephrine in the 50 ml syringes remained unchanged over a period of 2 months. After 28 days and 2 months of refrigerated storage the concentration amounted to 100.5% and 100.8% of the nominal concentration, respectively. Neither adrenochrome (detection wavelength 480 nm) nor any other degradation products were detected during the study period. With regard to these results batch production is feasible. Stability over 2 months is assured. Conclusions Epinephrine solution for injection 20 µg/ml, aseptically prepared by diluting the marketed injection concentrate with 5% glucose infusion solution in 50 ml light-protected plastic syringes, is stable under refrigerated storage conditions for at least 2 months. No conflict of interest. ER -